Prognostic implication of predominant histologic subtypes of lymph node metastases in surgically resected lung adenocarcinoma

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Suda, Kenichi ^a   Sato, Katsuaki ^a   Shimizu, Shigeki ^b   Tomizawa, Kenji ^a   Takemoto, Toshiki ^a   Iwasaki, Takuya ^a   Sakaguchi, Masahiro ^a   Mitsudomi, Tetsuya ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACINAR CELL CARCINOMA; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG RESECTION; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PAPILLARY CARCINOMA; RECURRENCE FREE SURVIVAL; SOLID TUMOR; TREATMENT OUTCOME; TUMOR VOLUME; ADENOCARCINOMA; CLASSIFICATION; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; LUNG NEOPLASMS; LYMPH NODE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS;

EID: 84908346979     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/645681     Document Type: Article

References (12)

1. Siegel R., Ward E., Brawley O., Jemal A., Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer Journal for Clinicians 2011 61 4 212 236 10.3322/caac.20121 2-s2.0-80051580618
2. Travis W. D., Brambilla E., Muller-Hermelink H. K., Pathology and genetics: tumors of the lung, pleura, thymus and heart. World Health Organization Classification of Tumors 2004 Lyon, France IARC Press
3. Motoi N., Szoke J., Riely G. J., Seshan V. E., Kris M. G., Rusch V. W., Gerald W. L., Travis W. D., Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. The American Journal of Surgical Pathology 2008 32 6 810 827 10.1097/PAS.0b013e31815cb162 2-s2.0-46249096082
4. Travis W. D., Brambilla E., Noguchi M., Nicholson A. G., Geisinger K. R., Yatabe Y., Beer D. G., Powell C. A., Riely G. J., Van Schil P. E., Garg K., Austin J. H. M., Asamura H., Rusch V. W., Hirsch F. R., Scagliotti G., Mitsudomi T., Huber R. M., Ishikawa Y., Jett J., Sanchez-Cespedes M., Sculier J.-P., Takahashi T., Tsuboi M., Vansteenkiste J., Wistuba I., Yang P.-C., Aberle D., Brambilla C., Flieder D., Franklin W., Gazdar A., Gould M., Hasleton P., Henderson D., Johnson B., Johnson D., Kerr K., Kuriyama K., Lee J. S., Miller V. A., Petersen I., Roggli V., Rosell R., Saijo N., Thunnissen E., Tsao M., Yankelewitz D., International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. Journal of Thoracic Oncology 2011 6 2 244 285 10.1097/JTO.0b013e318206a221 2-s2.0-79551563284
5. Warth A., Muley T., Meister M., Stenzinger A., Thomas M., Schirmacher P., Schnabel P. A., Budczies J., Hoffmann H., Weichert W., The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. Journal of Clinical Oncology 2012 30 13 1438 1446 10.1200/JCO.2011.37.2185 2-s2.0-84860379332
6. Yoshizawa A., Motoi N., Riely G. J., Sima C. S., Gerald W. L., Kris M. G., Park B. J., Rusch V. W., Travis W. D., Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: Prognostic subgroups and implications for further revision of staging based on analysis of 514 stage i cases. Modern Pathology 2011 24 5 653 664 10.1038/modpathol.2010.232 2-s2.0-79955571953
7. Russell P. A., Wainer Z., Wright G. M., Daniels M., Conron M., Williams R. A., Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new international association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary lung adenocarcinoma classification. Journal of Thoracic Oncology 2011 6 9 1496 1504 10.1097/JTO.0b013e318221f701 2-s2.0-80052264344
8. Hung J.-J., Jeng W.-J., Chou T.-Y., Hsu W.-H., Wu K.-J., Huang B.-S., Wu Y.-C., Prognostic value of the new international association for the study of lung cancer/American thoracic society/European respiratory society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma. Annals of Surgery 2013 258 6 1079 1086 10.1097/SLA.0b013e31828920c0 2-s2.0-84888138347
9. Hung J.-J., Yeh Y.-C., Jeng W.-J., Predictive value of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of lung adenocarcinoma in tumor recurrence and patient survival. Journal of Clinical Oncology 2014 10.1200/JCO.2013.50.1049
10. Sica G., Yoshizawa A., Sima C. S., Azzoli C. G., Downey R. J., Rusch V. W., Travis W. D., Moreira A. L., A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage i tumors. American Journal of Surgical Pathology 2010 34 8 1155 1162 10.1097/PAS.0b013e3181e4ee32 2-s2.0-77955172727
11. Russell P. A., Barnett S. A., Walkiewicz M., Wainer Z., Conron M., Wright G. M., Gooi J., Knight S., Wynne R., Liew D., John T., Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients. Journal of Thoracic Oncology 2013 8 4 461 468 10.1097/JTO.0b013e3182828fb8 2-s2.0-84875405224
12. Pignon J.-P., Tribodet H., Scagliotti G. V., Douillard J.-Y., Shepherd F. A., Stephens R. J., Dunant A., Torri V., Rosell R., Seymour L., Spiro S. G., Rolland E., Fossati R., Aubert D., Ding K., Waller D., Le Chevalier T., Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group. Journal of Clinical Oncology 2008 26 21 3552 3559 10.1200/JCO.2007.13.9030 2-s2.0-49049109683